Finally, using preclinical mouse models of human T-ALL, we demonstrate that human monocytes (Mos) engineered to express p21 could be used to home the tumor bed, to promote the phagocytosis of cancer cells after Mo differentiation into TAMs, to subvert anti-inflammatory TAMs and to reduce tumor growth. The gene discussed is CDKN1A; the disease is acute lymphoblastic leukemia.